Earnings History Data for Galectin Therapeutics (GALT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Galectin Therapeutics
Galectin Therapeutics Inc. is a drug development company engaged in the development new therapies for fibrotic disease and cancer. The Company uses its carbohydrate technology that targets galectin proteins, the key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Galectin Therapeutics, formerly known as Pro-Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | GALT | Galectin Therapeutics | 184.00 | -0.18 | -0.20 | 0.00 | Galectin Therapeutics GAAP EPS of -$0.18 [11/14/2024 2:22 PM] |
2.76 | -0.14 (-4.83%) |
2.90 | 0.0 (0.00%) |
1.55 - 4.27 | 139,649 | 160,000 | 1,521 | ||
| 13-08-2024 | PM | GALT | Galectin Therapeutics Inc. | 133.00 | -0.20 | -0.16 | -0.15 | Galectin Therapeutics GAAP EPS of -$0.20 [8/13/2024 8:52 AM] |
2.23 | 0.12 (5.69%) |
2.08 | -0.03 (-1.42%) |
1.46 - 4.27 | 101,078 | 120,000 | 1,240 | ||
| 15-05-2024 | PM | GALT | Galectin Therapeutics | 191.00 | -0.19 | -0.16 | 0.00 | Galectin Therapeutics GAAP EPS of -$0.19 [5/15/2024 8:50 AM] |
3.07 | 0.23 (8.10%) |
0.0 | 0.0 (0.00%) |
1.28 - 4.27 | 119,315 | 180,000 | 0 | ||
| 14-08-2023 | PM | GALT | Galectin Therapeutics | 86.00 | -0.15 | -0.21 | 0.00 | Galectin Therapeutics GAAP EPS of -$0.15 [8/14/2023 9:29 AM] |
1.50 | 0.01 (0.67%) |
0.0 | 0.0 (0.00%) |
1.02 - 2.47 | 43,549 | 50,000 | 0 | ||
| 14-11-2022 | PM | 8:00 AM ET (Nov 14) |
GALT | Galectin Therapeutics | 68.00 | -0.14 | -0.20 | 0.00 | Galectin Therapeutics GAAP EPS of -$0.14 [11/14/2022 8:52 AM] |
1.30 | 0.08 (6.37%) |
0.0 | 0.0 (0.00%) |
1.13 - 3.04 | 54,153 | 80,000 | 0 | |
| 31-03-2022 | PM | GALT | Galectin Therapeutics Inc. | 98.51 | -0.13 | 0.00 | -0.14 | Galectin Therapeutics GAAP EPS of -$0.52 beats by $0.07 [3/31/2022 9:22 AM] |
1.59 | -0.12 (-7.02%) |
1.86 | 0.15 (8.77%) |
1.59 - 5.70 | 282,318 | 90,000 | 4,464 | ||
| 17-05-2021 | PM | GALT | Galectin Therapeutics Inc. | 240.63 | -0.11 | -0.17 | -0.06 | Galectin Therapeutics EPS beats by $0.06 [5/17/2021 8:34 AM] |
4.35 | 0.12 (2.84%) |
4.13 | -0.10 (-2.36%) |
1.82 - 5.70 | 873,744 | 1,070,000 | 3,437 | ||
| 31-03-2021 | PM | GALT | Galectin Therapeutics Inc. | 118.00 | -0.14 | -0.16 | 0.00 | Galectin Therapeutics EPS beats by $0.02 [3/31/2021 8:42 AM] |
2.19 | 0.16 (7.88%) |
2.09 | 0.06 (2.96%) |
1.65 - 3.85 | 220,019 | 190,000 | 1,499 | ||
| 09-11-2020 | PM | GALT | Galectin Therapeutics Inc. | 147.83 | -0.10 | -0.14 | -0.05 | Galectin Therapeutics reports Q3 results [11/9/2020 8:18 AM] |
2.79 | 0.10 (3.72%) |
2.52 | 0.0 (0.00%) |
1.50 - 4.50 | 199,303 | 156,603 | 895 | ||
|
|
||||||||||||||||||